Legend Biotech.
Biotech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 30
What's happening
Earlier this month
One to three months ago
-
Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.Well supported5 reports
-
Analysts view Legend Biotech's current valuations as a buying opportunity.Speculative1 report1 development inside
-
Royal Bank of Canada cut its price target on Legend Biotech in a research report.Some support2 reports
-
Legend Biotech listed its shares on the Nasdaq stock exchange and expanded its global market presence into Ireland.Some support3 reports
-
Legend Biotech and Janssen Biotech announced a partnership on January 22, 2026, to advance cell therapy treatments. The companies are headquartered in Somerset, New Jersey.Some support1 report
-
Carlos Santos was appointed CFO of Legend Biotech, with financial expertise provided by AstraZeneca, Novartis, and Intel.Well supported5 reports
Gone quiet
No new reports in 90+ days-
Micron Technology, AAON, Legend Biotech, and Franco-Nevada saw stock movements on August 12, 2025, following earnings reports, including surges, plunges, and rises.Some support1 report
-
Legend Biotech reported record CARVYKTI sales driving revenue growth, coinciding with an FDA label update to reduce monitoring.Some support1 report
-
Legend Biotech reported a Q2 beat, indicating strong demand and successful manufacturing.Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Legend Biotech
Events traced to Legend Biotech, step by step, newest firstAround Legend Biotech this week
News at the entities that move Legend Biotech most-
Johnson & Johnson StructuralJohnson & Johnson was referenced in a recent news report concerning New York City.Moves Legend Biotech
-
Novartis StructuralSean Maenpaa, with experience at Novartis and Celgene, was appointed SVP Business Development at Clovis Oncology.Moves Legend Biotech
-
Morgan Stanley Mentioned togetherDuke Energy Florida launched a new solar site and Morgan Stanley raised its price target for Duke Energy.Moves Legend Biotech
-
LinkedIn OperationalA dispute arose over false and defamatory advertisements involving a son's LinkedIn profile, operating under Pennsylvania state law.Moves Legend Biotech
-
Nasdaq StructuralLockheed Martin was listed among active companies on October 12, 2026.Moves Legend Biotech
-
BioTech OperationalPDS Biotechnology and the National Cancer Institute entered into a collaborative R&D agreement.Moves Legend Biotech
Connections
The 15 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Johnson & Johnson Structural
Legend Biotech and Johnson & Johnson maintain a deep structural partnership, co-developing and supplying the CARVYKTI treatment, cemented by J&J's investment in Legend's portfolio.
-
Ying Huang Structural
Ying Huang served as the Chief Executive Officer and Board member of Legend Biotech.
-
CAR Structural
The company's existence is fundamentally tied to the single CAR-T franchise technology.
-
Janssen Biotech Operational
Legend Biotech and Janssen Biotech are partnering to advance cell therapy treatments.
-
Novartis Structural
Legend Biotech leverages expertise and talent pools from Novartis, indicating a functional dependency on Novartis's ecosystem.
-
Carlos Santos Structural
Carlos Santos serves as the Chief Financial Officer of Legend Biotech.
-
Nasdaq Structural
Legend Biotech is formally listed and trades on the Nasdaq stock exchange, establishing a market dependency.
-
LinkedIn Operational
Legend Biotech utilizes LinkedIn as a platform for maintaining its professional presence.
Show all 15 connections
-
BioTech Operational
Both companies are described as competing for investment within the healthcare sector.
-
New Jersey Shared context
Legend Biotech is headquartered in Somerset, New Jersey.
-
Janssen Operational
The relationship is defined by a collaboration agreement that drives higher sales for Legend Biotech.
-
Royal Bank of Canada Mentioned together
Legend Biotech is the subject of financial analysis and valuation reports from the investment banking sector represented by Royal Bank of Canada.
-
AbbVie Mentioned together
Both entities are cited as major players operating within the competitive pharmaceutical sector.
-
Morgan Stanley Mentioned together
Morgan Stanley provides investment coverage, including target price and rating changes, for Legend Biotech.
-
Ireland Shared context
Legend Biotech is expanding its market presence and launching products in Ireland.
History
Events by the month they beganOctober 2026
1 eventAugust 2026
3 events- Royal Bank of Canada cut its price target on Legend Biotech in a research report.
- Legend Biotech listed its shares on the Nasdaq stock exchange and expanded its global market presence into Ireland.
- Legend Biotech and Janssen Biotech announced a partnership on January 22, 2026, to advance cell therapy treatments. The companies are headquartered in Somerset, New Jersey.
June 2026
6 events- Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.
- Analysts view Legend Biotech's current valuations as a buying opportunity.
- Carlos Santos was appointed CFO of Legend Biotech, with financial expertise provided by AstraZeneca, Novartis, and Intel.
- Micron Technology, AAON, Legend Biotech, and Franco-Nevada saw stock movements on August 12, 2025, following earnings reports, including surges, plunges, and rises.
- Legend Biotech reported record CARVYKTI sales driving revenue growth, coinciding with an FDA label update to reduce monitoring.
- Legend Biotech reported a Q2 beat, indicating strong demand and successful manufacturing.